# Guard Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/guard-medical

- Industry: Medical Devices & Equipment
- Headquarters: Miami, US
- Website: www.guard-medical.com
- Total disclosed funding: $11M
- Latest round: Series B (Apr 5, 2022)
- Investors on record: 2

## About

Founded in 2020, and based in Florida, US, Guard Medical Inc. engages in developing a negative pressure surgical system to reduce infections. In April 2022, Guard Medical Inc. raised USD 11 million in Series B funding from Bpifrance Investissement and Matignon Investissement et Gestion. As of 2022, Machiel van der Leest is the CEO of the company.

The company provides NPseal™, a product that improves the lives of surgical patients by utilizing negative pressure wound healing. The NPWT is a wearable surgical dressing with an integrated pump that promotes healing and lowers surgical site infections (SSI) in closed surgical incisions. Guard Medical's NPseal supports surgical procedures such as general surgery, colorectal surgery, plastic and reconstructive surgery, obstetrics, orthopedics, and dermatology.  

The organization plans to use the April 2022 investment to support its commercialization and clinical studies of its negative pressure wound therapy (NPWT) dressing NPseal.

## Funding rounds

- Series B, Apr 5, 2022, $11M — Matignon Investissement et Gestion, Bpifrance Investissement

## Investors

- Matignon Investissement et Gestion (https://capitalatlas.ai/funds/matignon-investissement-et-gestion) — Series B
- Bpifrance Investissement (https://capitalatlas.ai/funds/bpifrance-investissement) — Series B